ABSTRACT
The outbreak of the novel coronavirus pneumonia (NCP), an acute infectious respiratory disease in Wuhan, China in December 2019, which was officially named COVID-19 by WHO, has caused enormous burden on society and health services. To ensure safe rehabilitation practice during the epidemic, the Chinese Association of Rehabilitation Medicine formed an expert group to develop a consensus statement for rehabilitation practice. The consensus statement provides guidance on: (1) safeguarding medical staff, patients, caregivers and visitors; and (2) timing and methods of effective rehabilitation interventions for treatment of COVID-19 patients. It also emphasizes that non-COVID-19 patients still require rehabilitation intervention during the epidemic outbreak, bearing in mind the safety of staff and patients and making adaptations according to the individual conditions and the patients′ actual environment. This expert consensus statement applies to departments of rehabilitation medicine and related disciplines in general hospitals as well as to specialized rehabilitation facilities, and it provides valuable reference for rehabilitation professionals working with infectious respiratory diseases in the future.
ABSTRACT
Recently, along with the harmful factors in air in-creasing, the incidence of respiratory system diseases has been gradually rising. Therefore, more studies are focused on impro-ving the prevention and treatment on respiratory system diseases. Current researches have shown that microRNAs ( miRNA ) con-tribute to the prevention and treatment on respiratory system dis-eases, including virus infectious respiratory disease, pulmonary fibrosis, asthma, COPD, pulmonary tuberculosis and lung canc-er. The up-regulation and down-regulation of microRNAs could effectively regulate the biological process of these diseases. The review analyzes the recent years′study results of respiratory sys-tem diseases and microRNAs in depth, and discuss the role of microRNA in the treatment and prevention of respiratory disea-ses. Moreover, in this review we can provide new knowledge a-bout respiratory diseases and development of more potent drug targets for the treatment and prevention of respiratory diseases.